Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

Part of paid clinical trials in Orlando, Florida.

Sponsor
Pfizer
Study ID
NCT03041792
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Liraglutide — DRUG
    Liraglutide
  • Placebo — OTHER
    Placebo

Study Details

This will be a randomized, double blind, placebo controlled, 2 arm, parallel group, methodology study to assess the effect of 6 weeks of liraglutide administration on food intake in obese subjects.

Key Dates

Start date
Feb 20, 2017
Status verified
May 2019
Primary completion
Jan 16, 2018
Completion
Jan 16, 2018

Study Design

Enrollment
61 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Active
    Liraglutide
  • Placebo Comparator: Placebo
    Placebo comparator

Primary Outcome Measure

Change From Baseline (Visit 3) in Mean Energy Intake During Ad Libitum Lunches at Visits 4 and 5 [ Time Frame: Visit 3, Visit 4 and Visit 5 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Translational Research Institute for Metabolism and DiabetesOrlandoFlorida32804-

Find similar trials in Orlando, FL

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Translational Research Institute for Metabolism and Diabetes· Orlando, FL

Related Studies